Catrin M. Lutz
Utrecht, UT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Patient-derived xenograft models of primary breast cancer for preclinical evaluation of neoadjuvant therapies.
Journal: Science translational medicine
Published: March 18, 2026
Beyond the chaos: How architecture structures tumour biology.
Journal: The FEBS journal
Published: May 23, 2025
The C-Terminal Kinase Domain-Binding and Suppression Motif Prevents Constitutive Activation of FGFR2.
Journal: Cancer research
Published: September 12, 2024
The complex landscape of luminal breast cancer.
Journal: Endocrine-related cancer
Published: August 04, 2024
C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3.
Journal: Cancer research
Published: July 26, 2024
Large-scale Characterization of Orthotopic Cell Line-Derived Xenografts Identifies TGFβ Signaling as a Key Regulator of Breast Cancer Morphology and Aggressiveness.
Journal: Cancer research
Published: June 16, 2024
Rat Models of Hormone Receptor-Positive Breast Cancer.
Journal: Journal of mammary gland biology and neoplasia
Published: March 29, 2024
Fasting boosts breast cancer therapy efficacy via glucocorticoid activation.
Journal: Nature
Published: February 29, 2024
Luminal breast cancer identity is determined by loss of glucocorticoid receptor activity.
Journal: EMBO molecular medicine
Published: March 21, 2023
Mechanisms that clear mutations drive field cancerization in mammary tissue.
Journal: Nature
Published: December 13, 2022
Last Updated: 09/26/2026